PMID- 29084410
OWN - NLM
STAT- MEDLINE
DCOM- 20180813
LR  - 20180813
IS  - 1423-0399 (Electronic)
IS  - 0042-1138 (Linking)
VI  - 100
IP  - 1
DP  - 2018
TI  - Significance of MRI/Transrectal Ultrasound Fusion Three-Dimensional Model-Guided,
      Targeted Biopsy Based on Transrectal Ultrasound-Guided Systematic Biopsy in
      Prostate Cancer Detection: A Systematic Review and Meta-Analysis.
PG  - 57-65
LID - 10.1159/000484144 [doi]
AB  - PURPOSE: To assess MRI/Transrectal Ultrasound (TRUS) fusion three-dimensional
      model-guided targeted biopsy (3D-Tb) versus TRUS-guided systematic biopsy (Sb) in
      detecting overall and high-Gleason-score (>/=7) prostate cancer (PCa). METHODS:
      Pubmed and Web of science were searched. Studies with men having a suspicious
      lesion on MRI were included, which were divided into initial biopsy, previous
      negative biopsy, and mixed groups in meta-analysis. RESULTS: Totally 13 cohorts
      in 12 studies, with 3,225 men were included. In total population, 3D-Tb and Sb
      did not differ significantly in the PCa detection rate (43.1 vs. 42.6%, p =
      0.36), but after excluding initial biopsy group, the superiority of 3D-Tb became 
      significant (p = 0.01); 3D-Tb had a significantly higher detection rate of
      high-Gleason-score PCa compared to Sb (30.0 vs. 24.1%, p < 0.05); 3D-Tb plus Sb
      significantly improved the PCa detection rate based on Sb alone (52.7 vs. 42.6%, 
      p < 0.05). CONCLUSIONS: In men with increased serum PSA and/or abnormal DRE and
      suspicious lesion on MRI but non-previous evidence of PCa, 3D-Tb plus Sb improves
      the PCa detection rate based on Sb alone. 3D-Tb alone has better performance in
      detecting high-Gleason-score PCa, and tends to have a higher PCa detection rate
      in population with previous negative biopsy compared to Sb.
CI  - (c) 2017 S. Karger AG, Basel.
FAU - Tang, Yongquan
AU  - Tang Y
AD  - Department of Urology/Institute of Urology, West China School of Medicine/West
      China Hospital, Sichuan University, Chengdu, China
FAU - Liu, Zhihong
AU  - Liu Z
FAU - Tang, Liangyou
AU  - Tang L
FAU - Zhang, Ruochen
AU  - Zhang R
FAU - Lu, Yiping
AU  - Lu Y
FAU - Liang, Jiayu
AU  - Liang J
FAU - Zou, Zijun
AU  - Zou Z
FAU - Zhou, Chuan
AU  - Zhou C
FAU - Wang, Yujie
AU  - Wang Y
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
DEP - 20171030
PL  - Switzerland
TA  - Urol Int
JT  - Urologia internationalis
JID - 0417373
SB  - IM
MH  - Humans
MH  - Image-Guided Biopsy
MH  - *Imaging, Three-Dimensional
MH  - *Magnetic Resonance Imaging
MH  - Male
MH  - Multimodal Imaging
MH  - Prostatic Neoplasms/*diagnostic imaging/*pathology
MH  - Rectum
MH  - *Ultrasonography, Interventional/methods
OTO - NOTNLM
OT  - *Magnetic resonance imaging
OT  - *Prostate biopsy
OT  - *Prostate cancer
OT  - *Transrectal ultrasound
EDAT- 2017/10/31 06:00
MHDA- 2018/08/14 06:00
CRDT- 2017/10/31 06:00
PHST- 2017/07/04 00:00 [received]
PHST- 2017/10/10 00:00 [accepted]
PHST- 2017/10/31 06:00 [pubmed]
PHST- 2018/08/14 06:00 [medline]
PHST- 2017/10/31 06:00 [entrez]
AID - 000484144 [pii]
AID - 10.1159/000484144 [doi]
PST - ppublish
SO  - Urol Int. 2018;100(1):57-65. doi: 10.1159/000484144. Epub 2017 Oct 30.